Novo Nordisk, the world's leading biopharmaceutical company, is known for the development and research of insulin, originated in 1923, headquartered in Copenhagen, Denmark. Novo Nordisk is also the first company to launch long-acting insulin, premixed insulin, high-purity insulin, human insulin and insulin injection pen.